From: Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results
 |  | n | Total group (N = 151) |  | Preclinical AD (n = 28) | Subthreshold psychiatry (n = 58) | Undetermined (n = 65) | p |
---|---|---|---|---|---|---|---|---|
Demographics | Age | 151 | 64 ± 8 |  | 69 ± 7b | 62 ± 8a | 64 ± 8a | 0.002 |
Gender, female | 151 | 67 (44) | Â | 11 (39) | 27 (47) | 29 (45) | NS | |
Education (years) | 148 | 12 ± 3 |  | 13 ± 3 | 12 ± 3 | 12 ± 2 | NS | |
Family history dementia | 140 | 76 (54) | Â | 18 (75)b | 20 (36)a | 38 (62)b | 0.002 | |
APOE e4 carrier | 144 | 55 (38) | Â | 17 (65)b | 17 (30)a | 21 (34)a | 0.007 | |
 |  |  | n above cutoff value |  |  |  |  | |
Subjective cognitive decline | SCF (1-year change) self-report | 150 | −1.65 ± 2.98 | 104 (69) | −2.0 ± 2.3 | −2.4 ± 3.2 | −0.8 ± 2.9b | 0.004 |
CCI (5-year change) self-reportc | 148 | 21.8 ± 14.3 | 89 (60) | 21.4 ± 13.2b | 27.8 ± 15.2a | 16.7 ± 11.8b | 0.000 | |
CCI (5-year change) informantc | 127 | 19.4 ± 17.1 | 62 (49) | 19.8 ± 13.9b | 26.4 ± 19.1a | 13.8 ± 14.8b | 0.000 | |
Mental health questionnaires | Quality of Life | 149 | 76 ± 15 |  | 79 ± 12 | 71 ± 16 | 80 ± 15b | 0.012 |
Depressive symptomsc | 150 | 8.3 ± 6.4 | 17 (11) | 7.0 ± 4.6 | 12.1 ± 7.3 | 5.5 ± 4.1 | 0.000 | |
Anxietyc | 150 | 4.0 ± 2.9 | 13 (13) | 4.1 ± 2.6 | 5.6 ± 3.1 | 2.4 ± 1.9 | 0.000 | |
Distressc | 150 | 6.7 ± 5.9 | 34 (22) | 4.6 ± 4.6 | 11.1 ± 6.3 | 3.6 ± 2.9 | 0.000 | |
Somatizationc | 151 | 6.3 ± 5.3 | 31 (21) | 4.6 ± 3.7 | 10.3 ± 5.7 | 3.5 ± 2.8 | 0.000 | |
Neuroticismc | 145 | 6.6 ± 5.5 |  | 5.2 ± 3.8 | 10.1 ± 6.4 | 4.0 ± 2.8 | 0.000 | |
Low masteryc | 140 | 10.5 ± 3.9 |  | 10.0 ± 3.0 | 12.8 ± 4.0 | 8.5 ± 2.7 | 0.000 | |
Cognition | MMSE | 151 | 28.6 ± 1.2 |  | 28.4 ± 1.3 | 28.5 ± 1.2 | 28.9 ± 1.2 | 0.031 |
 Memory domain | RAVLT immediate recall | 149 | 44.3 ± 9.0 |  | 43.4 ± 8.7 | 44.0 ± 9.0 | 44.6 ± 9.2 | NS |
RAVLT delayed recall | 149 | 9.0 ± 2.9 |  | 8.5 ± 2.9 | 9.1 ± 3.0 | 9.2 ± 2.9 | NS | |
RAVLT cued recall | 149 | 28.7 ± 1.6 |  | 28.7 ± 1.5 | 28.5 ± 2.3 | 28.8 ± 1.4 | NS | |
 Attention | TMT Ac | 148 | 34.4 ± 12.8 |  | 33.4 ± 12.2b | 37.5 ± 14.9a | 32.1 ± 10.5b | 0.014 |
 Executive functioning | TMT Bc | 147 | 82.1 ± 33.2 |  | 79.5 ± 28.9 | 89.8 ± 41.0 | 76.2 ± 25.8b | 0.058 |
 Language | Animal fluency | 147 | 23.2 ± 5.2 |  | 22.8 ± 4.9 | 23.1 ± 5.1 | 23.5 ± 5.6 | NS |
MRI | Normalized brain volume (ml) | 116 | 1399 ± 79 |  | 1366 ± 75 | 1407 ± 81 | 1406 ± 79 | NS |
Bilateral hippocampal volume (ml) | 116 | 9.9 ± 1.3 |  | 10.0 ± 1.4 | 9.9 ± 1.3 | 9.8 ± 1.1 | NS | |
White-matter hyperintensities (present) | 116 | 10 (9) | Â | 2 (9) | 2 (4) | 6 (13) | NS | |
Lacunes (> 0) | 115 | 3 (3) |  | 1 (4) | 2 (5) | 0 (0) | NS | |
Microbleeds present (> 0) | 112 | 19 (17) |  | 7 (30) | 4 (10) | 8 (17) | NS |